Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 7, 2014; 20(37): 13343-13368
Published online Oct 7, 2014. doi: 10.3748/wjg.v20.i37.13343
Table 4 Antigenic sources used in pancreatic cancer vaccine trials
Peptide or protein vaccinesMutant K-ras peptide
WT1 peptide
CAP1-6D
G17DT
HLA-A*0201 restricted VEGF receptor-1 and -2 peptides
HLA-A24 restricted survivin-2B80-88 peptide (AYACNTSTL)
Autologous heat shock protein HSPPC-96
TELOVAC
Whole cell vaccines or dendritic cell vaccinesα-Gal transferase transfected allogeneic tumor cells (including Algenpantucel-L)
GVAX
MUC-1 pulsed autologous dendritic cells
Viral or bacterial vaccinesPANVAC-VF-MUC-1, CEA, and TRICOM transfected virus
Mesothelin (CRS-207) transfected live-attenuated Listeria
DNA vaccinesVXMO1